back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-03-29 15:30 Tx date 2020-03-26 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-338,445
-32,700 vol $10.35 each |
425,000 | |
| Filed 2019-08-15 15:57 Tx date 2019-08-13 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-164,600
-20,000 vol $8.23 each |
457,700 | |
| Filed 2019-03-20 Tx date 2019-03-15 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$391,000
+100,000 vol $3.91 each |
477,700 | |
| Filed 2019-03-20 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
377,700 | ||
| Filed 2018-08-21 Tx date 2018-08-16 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-49,800
-10,000 vol $4.98 each |
29,093 | |
| Filed 2018-06-28 Tx date 2018-06-27 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-21,403.46
-5,603 vol $3.82 each |
39,093 | |
| Filed 2018-06-26 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
48,696 | ||
| Filed 2018-06-26 Tx date 2018-06-21 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-14,880
-4,000 vol $3.72 each |
44,696 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-3,238 vol |
0 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,884 vol |
48,696 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,952
+11,806 vol $1.69 each |
46,812 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-79,430
-47,000 vol $1.69 each |
377,700 | |
| Filed 2018-03-27 Tx date 2018-03-23 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$238,750
+125,000 vol $1.91 each |
424,700 | |
| Filed 2017-04-07 Tx date 2017-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,856 vol |
35,006 | |
| Filed 2017-04-07 Tx date 2017-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-3,238 vol |
3,238 | |
| Filed 2017-03-27 Tx date 2017-03-22 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$378,750
+125,000 vol $3.03 each |
299,700 | |
| Filed 2016-08-15 Tx date 2016-08-12 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,186
+31,093 vol $3.19 each |
33,150 | |
| Filed 2016-06-30 Tx date 2016-06-27 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,057 vol |
2,057 | |
| Filed 2016-06-30 Tx date 2016-06-27 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-3,238 vol |
6,476 | |
| Filed 2016-06-30 Tx date 2012-11-01 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-24 Tx date 2016-06-21 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$363,000
+75,000 vol $4.84 each |
174,700 |